Evidence map›Paper›PMID 18179882›Full record

ArticleAmerican journal of human genetics2008

C6ORF66 is an assembly factor of mitochondrial complex I.

Ann Saada, Simon Edvardson, Matan Rapoport, Avraham Shaag, Khaled Amry, Chaya Miller, Haya Lorberboum-Galski, Orly Elpeleg

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 159 citations in OpenAlex.

  1. Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  2. Article
  3. Article
  4. Using cryo-EM to understand the assembly pathway of respiratory complex I.Acta crystallographica. Section D, Structural biology · 2024
    Article
  5. Article
  6. Frontiers in immunology · 2024
    Article
  7. Nickel(II) Phototheranostics: A Case Study in Photoactivated HJournal of the American Chemical Society · 2023
    Article
  8. Mitochondrial Epilepsy, a Challenge for Neurologists.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions.International journal of molecular sciences · 2021
    Review
  15. Leigh Syndrome: A Tale of Two Genomes.Frontiers in physiology · 2021
    Review
  16. Review
  17. Article
  18. Plant direct · 2020
    Article
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ann SaadaMetabolic Disease Unit and, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Simon Edvardson
Matan Rapoport
Avraham Shaag
Khaled Amry
Chaya Miller
Haya Lorberboum-Galski
Orly Elpeleg
Hadassah Medical Center · ILHebrew University of Jerusalem · ILPalestinian Hydrology Group · PS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homozygosity mapping was performed in five patients from a consanguineous family who presented with infantile mitochondrial encephalomyopathy attributed to isolated NADH:ubiquinone oxidoreductase (complex I) deficiency. This resulted in the identification of a missense mutation in a conserved residue of the C6ORF66 gene, which encodes a 20.2 kDa mitochondrial protein. The mutation was also detected in a patient who presented with antenatal cardiomyopathy. In muscle of two patients, the levels of the C6ORF66 protein and of the fully assembled complex I were markedly reduced. Transfection of the patients' fibroblasts with wild-type C6ORF66 cDNA restored complex I activity. These data suggest that C6ORF66 is an assembly factor of complex I. Interestingly, the C6ORF66 gene product was previously shown to promote breast cancer cell invasiveness.

Indexed as

Calmodulin-Binding ProteinsChildChild, PreschoolConsanguinityElectron Transport Complex IFemaleHumansInfantInfant, NewbornMaleMitochondrial DiseasesMitochondrial ProteinsMutation, MissensePedigreeCalmodulin-Binding ProteinsElectron Transport Complex IMitochondrial ProteinsNDUFAF4 protein, human

Identifiers

PMID18179882
PMCPMC2253982
OpenAlexW2089164902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.